AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimzy M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Zylig Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimzy M 1mg/500mg Tablet ER

Diabex Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, increasing the risk of complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan, including dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse effect of Diabex Duo is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to counteract them. Regular meals and carrying a quick-acting glucose source (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption raises hypoglycemia risk and should be limited. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Diabex Duo's suitability during pregnancy or breastfeeding requires medical consultation. Regular blood glucose monitoring is mandatory, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimzy M 1mg/500mg Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Glimzy M 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimzy M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimzy M 1mg/500mg Extended-Release tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with food.

Common Side effects of Glimzy M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimzy M 1mg/500mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimzy M 1mg/500mg Extended-Release Tablet with food.

How Glimzy M 1mg/500mg Tablet ER works:

Glimzy M ER tablets (1mg/500mg) combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimzy M 1mg/500mg Extended-Release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimzy M 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimzy M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant harm from the medication's toxic effects.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimzy M 1mg/500mg Extended-Release tablets; dosage modification may be necessary. Consult your physician for guidance. Glimzy M 1mg/500mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimzy M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, initiation with a low dose is typical; however, the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glimzy M 1mg/500mg Tablet ER :

Should you forget to take your Glimzy M 1mg/500mg Extended-Release tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimzy M 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimzy M 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimzy M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimzy M 1mg/500mg Tablet ER and seek immediate medical attention.
Glimzy M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with a healthy diet and exercise regimen. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimzy M 1mg/500mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimzy M 1mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glimzy M 1mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimzy M 1mg/500mg ER tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimzy M 1mg/500mg Tablet...
72
MRP 83
13% off